Skip to content

oral calcium and magnesium on the reduction of pms

Comparative study of the effect of oral calcium and magnesium on the reduction of PMS

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160709028844N1
Enrollment
195
Registered
2023-04-26
Start date
2018-11-21
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual syndrome. Premenstrual tension syndrome

Interventions

Intervention 1: Group A consumed 1000 mg of calcium per day for the study period of 3 cycles from the 15th day of the menstrual cycle or immediately after ovulation to the start of menstrual bleeding,

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 27 Years

Inclusion criteria

Inclusion criteria: Female students of Shahrekord University of Medical Sciences with definite diagnosis of premenstrual syndrome Not using other treatment methods Willingness to participate in the study Not suffering from known physical and mental diseases single Calendar age 18 to 27 years Regular menstrual cycle of 21 to 35 days Menstruation duration 3-7 days during the last six months In terms of the severity of PMS symptoms, they were matched according to the DSM-V score

Exclusion criteria

Exclusion criteria: Reluctance to participate in the study Use of other treatment methods

Design outcomes

Primary

MeasureTime frame
Premenstrual syndrome. Timepoint: The beginning of the study and 1, 2 and 3 months after the study. Method of measurement: PMS diagnostic criteria based on DSM-V.

Secondary

MeasureTime frame
Physical and mental symptoms. Timepoint: 0 start of study and 1 month, 2 months and 3 months later. Method of measurement: DSM-V.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSheida Shabanian

Shahre-kord University of Medical Sciences

shabanian@skums.ac.ir+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026